NSE ScannerHospitals & Diagnostics · Medical/Nursing Services · NSE: LAXMIDENTL · data 2026-10-30
Laxmi Dental Ltd.
In plain words
Price: 48.5% below its 52-week high of ₹344.8.
Delivery: 56.7% of traded shares were kept for delivery over the last 10 sessions, against 55.4% over the last 60.
Latest results: a net profit of ₹10 cr for the quarter ended Jun 2026 (+22.8% on the same quarter a year earlier).
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹287 cr |
| Net profit (last 12 months) | ₹31 cr |
| Sales growth, 3 years (yearly) | 20.5% |
| Profit growth, 3 years (yearly) | — |
Latest results in brief (Q1 FY27)
LAXMIDENTL Q1 FY27 results (consolidated figures, as filed on NSE).
Revenue was ₹74.7 crore, up 13.9% YoY and up 1% QoQ.
Net profit was ₹10.3 crore, up 22.8% YoY and up 2.2% QoQ.
Operating margin was 19.2% (18.2% a year ago).
EPS was ₹1.87, up 22.2% YoY and up 2.2% QoQ.
LAXMIDENTL के Q1 FY27 नतीजे (कंसोलिडेटेड आंकड़े, NSE पर दाखिल)।
राजस्व: ₹74.7 करोड़; पिछले साल की तुलना में 13.9% की बढ़त, पिछली तिमाही की तुलना में 1% की बढ़त।
शुद्ध मुनाफ़ा: ₹10.3 करोड़; पिछले साल की तुलना में 22.8% की बढ़त, पिछली तिमाही की तुलना में 2.2% की बढ़त।
ऑपरेटिंग मार्जिन: 19.2% (एक साल पहले 18.2%)।
EPS: ₹1.87; पिछले साल की तुलना में 22.2% की बढ़त, पिछली तिमाही की तुलना में 2.2% की बढ़त।
LAXMIDENTLના Q1 FY27 પરિણામો (કન્સોલિડેટેડ આંકડા, NSE પર ફાઇલ કરેલા).
આવક (રેવન્યુ): ₹74.7 કરોડ; ગયા વર્ષની સરખામણીએ 13.9% વધારો, ગયા ક્વાર્ટરની સરખામણીએ 1% વધારો.
ચોખ્ખો નફો: ₹10.3 કરોડ; ગયા વર્ષની સરખામણીએ 22.8% વધારો, ગયા ક્વાર્ટરની સરખામણીએ 2.2% વધારો.
ઓપરેટિંગ માર્જિન: 19.2% (એક વર્ષ પહેલાં 18.2%).
EPS: ₹1.87; ગયા વર્ષની સરખામણીએ 22.2% વધારો, ગયા ક્વાર્ટરની સરખામણીએ 2.2% વધારો.
Written from the filed numbers. Not a recommendation.
Smart-money activity
13/100 · Weak over the last ~60 sessions, data 2026-10-30
- Delivery vs usual 8/30: Delivery 59.9% over the last 20 sessions vs 55.4% in the 40 before (1.08x); shares delivered per day 0.69x usual; 1 delivery-spike day (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
- Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Story so far
● Results
- 11 Aug 26Results Q1 FY27 results: profit +22.8% YoY -7.1% next session
- 21 May 26Results Q4 FY26 results: profit +135.5% YoY +22.8% next session
- 10 Feb 26Results Q3 FY26 results: profit −58.8% YoY -7.0% next session
- 18 Dec 25Results Q2 FY26 results: net profit ₹8.5 cr +0.8% next session
- 12 Aug 25Results Q1 FY26 results: net profit ₹8.4 cr -3.0% next session
- 28 May 25Results Q4 FY25 results: net profit ₹4.3 cr -2.0% next session
- 14 Feb 25Results Q3 FY25 results: net profit ₹4.8 cr -11.4% next session
From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.
Quarterly results (consolidated)
| Quarter | Revenue | Net profit | Profit YoY | Op. margin | EPS ₹ |
|---|---|---|---|---|---|
| Jun 2026 | ₹75 cr | ₹10 cr | +22.8% | 19.2% | 1.87 |
| Mar 2026 | ₹74 cr | ₹10 cr | +135.5% | 18.3% | 1.83 |
| Dec 2025 | ₹66 cr | ₹2 cr | -58.7% | 10.5% | 0.37 |
| Sept 2025 | ₹72 cr | ₹9 cr | — | 15.3% | 1.59 |
Shareholding trend
| Holder | Sept 2026 | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|---|
| Promoters | 41.75% | 41.80% | 41.77% | 41.70% |
| Foreign institutions (FII) | 6.58% | 30.10% | 31.21% | 32.45% |
| Domestic institutions (DII) | 10.68% | 10.89% | 10.52% | 10.83% |
| Mutual funds | 9.77% | 10.11% | 10.32% | 10.71% |
| Retail investors | 11.27% | 9.82% | 9.53% | 8.19% |
| Number of shareholders | 36,680 | 36,937 | 38,161 | 38,635 |
Common questions
What was Laxmi Dental Ltd.'s latest quarterly profit?
Laxmi Dental Ltd. reported a net profit of ₹10 cr for the quarter ended Jun 2026 (+22.8% on the same quarter a year earlier), on revenue of ₹75 cr.
How much do promoters hold in Laxmi Dental Ltd.?
Promoters held 41.75% of Laxmi Dental Ltd. at the end of Sept 2026, with 0.00% of promoter shares pledged.
Is Laxmi Dental Ltd. debt-free?
Its latest reported debt-to-equity ratio is 0.05, which is very low.
What is Laxmi Dental Ltd.'s P/E ratio?
About 31.6, based on the last 12 months' earnings and a price of ₹177.58 (data 2026-10-30).
What is the 52-week high and low of Laxmi Dental Ltd.?
The 52-week high is ₹344.8 and the 52-week low is ₹155.88.
Similar companies
Suraksha Diagnostic Ltd. (SURAKSHA) · Krsnaa Diagnostics Limited (KRSNAA) · Unihealth Hospitals Ltd (UNIHEALTH) · Max India Ltd (MAXIND) · Gaudium IVF & Women Health Ltd. (GAUDIUMIVF)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open LAXMIDENTL in NSE Scanner →